These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2295222)

  • 1. Pharmacokinetics of ticarcillin in patients with cystic fibrosis: a controlled prospective study.
    de Groot R; Hack BD; Weber A; Chaffin D; Ramsey B; Smith AL
    Clin Pharmacol Ther; 1990 Jan; 47(1):73-8. PubMed ID: 2295222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vivo assessment of the tobramycin/ticarcillin interaction in cystic fibrosis patients.
    Roberts GW; Nation RL; Jarvinen AO; Martin AJ
    Br J Clin Pharmacol; 1993 Oct; 36(4):372-5. PubMed ID: 12959319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition of drugs in cystic fibrosis. IV. Mechanisms for enhanced renal clearance of ticarcillin.
    Wang JP; Unadkat JD; al-Habet SM; O'Sullivan TA; Williams-Warren J; Smith AL; Ramsey B
    Clin Pharmacol Ther; 1993 Sep; 54(3):293-302. PubMed ID: 8375124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics and antibacterial activity of ticarcillin in 11 patients with cystic fibrosis].
    de Meirleire F; Fauchere JL; Simon G
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):570-2. PubMed ID: 6431381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ticarcillin/clavulanic acid pharmacokinetics in children and young adults with cystic fibrosis.
    Jacobs RF; Trang JM; Kearns GL; Warren RH; Brown AL; Underwood FL; Kluza RB
    J Pediatr; 1985 Jun; 106(6):1001-7. PubMed ID: 3998937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of intravenously and intramuscularly administered ticarcillin and clavulanic acid in foals.
    Sweeney RW; Beech J; Simmons RD
    Am J Vet Res; 1988 Jan; 49(1):23-6. PubMed ID: 3354961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study of the effects of oral probenecid on the pharmacokinetics of intravenous ticarcillin in patients with cystic fibrosis.
    Corvaia L; Li SC; Ioannides-Demos LL; Bowes G; Spicer WJ; Spelman DW; Tong N; McLean AJ
    J Antimicrob Chemother; 1992 Dec; 30(6):875-8. PubMed ID: 1289366
    [No Abstract]   [Full Text] [Related]  

  • 8. Disposition of tobramycin in patients with cystic fibrosis: a prospective controlled study.
    Levy J; Smith AL; Koup JR; Williams-Warren J; Ramsey B
    J Pediatr; 1984 Jul; 105(1):117-24. PubMed ID: 6376743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin sensitivity and insulin clearance in cystic fibrosis patients with normal and diabetic glucose tolerance.
    Lanng S; Thorsteinsson B; Røder ME; Nerup J; Koch C
    Clin Endocrinol (Oxf); 1994 Aug; 41(2):217-23. PubMed ID: 7923827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of piperacillin, ticarcillin, and carbenicillin pharmacokinetics.
    Meyers BR; Hirschman SZ; Strougo L; Srulevitch E
    Antimicrob Agents Chemother; 1980 Apr; 17(4):608-11. PubMed ID: 6446878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of ticarcillin in patients with abnormal renal function.
    Parry MF; Neu HC
    J Infect Dis; 1976 Jan; 133(1):46-9. PubMed ID: 1107435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of ticarcillin/clavulanate in severely burned patients.
    Adam D; Zellner PR; Koeppe P; Wesch R
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():121-9. PubMed ID: 2606814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative pharmacokinetics of low- and high-dose ticarcillin.
    Guglielmo BJ; Flaherty JF; Batman R; Barriere SL; Gambertoglio JG
    Antimicrob Agents Chemother; 1986 Sep; 30(3):359-60. PubMed ID: 3777901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First population pharmacokinetic analysis showing increased quinolone metabolite formation and clearance in patients with cystic fibrosis compared to healthy volunteers.
    Jiao Y; Kim TH; Tao X; Kinzig M; Landersdorfer CB; Drescher SK; Sutaria DS; Moya B; Holzgrabe U; Sörgel F; Bulitta JB
    Eur J Pharm Sci; 2018 Oct; 123():416-428. PubMed ID: 30076955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probenecid pharmacokinetics in cystic fibrosis.
    Weber A; de Groot R; Ramsey B; Williams-Warren J; Smith A
    Dev Pharmacol Ther; 1991; 16(1):7-12. PubMed ID: 1879255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administration of ticarcillin in combination with clavulanic acid intravenously and intrauterinely to clinically normal oestrous mares.
    Van Camp SD; Papich MG; Whitacre MD
    J Vet Pharmacol Ther; 2000 Dec; 23(6):373-8. PubMed ID: 11168915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the biliary excretion of a ticarcillin-clavulanic acid combination in man].
    Brogard JM; Blickle JF; Jehl F; Adloff M; Monteil H
    Pathol Biol (Paris); 1988 May; 36(5):500-6. PubMed ID: 3043347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of azlocillin in children with cystic fibrosis.
    Bergan T; Michalsen H
    Arzneimittelforschung; 1979; 29(12a):1955-7. PubMed ID: 543899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacokinetics of ticarcillin/clavulanate acid in neonates.
    Fricke G; Doerck M; Hafner D; Horton R; Kresken M
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():111-20. PubMed ID: 2606813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of ticarcillin epimers in plasma and urine with high-performance liquid chromatography.
    Li YH; Itoh T; Tsuda Y; Ishida M; Watanabe N; Shimada H; Yamada H
    J Chromatogr B Biomed Sci Appl; 1997 Jun; 694(1):145-52. PubMed ID: 9234857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.